compared with healthy controls. The finding that is consistent with the study showing an increase in G72 transcripts in the postmortem brains from patients with schizophrenia 10 supports that G72 is a susceptibility protein. To our knowledge, the current study is the first one indicating that the peripheral expression of a single protein may have the potential to be a diagnostic biomarker for schizophrenia with favorable sensitivity and specificity.
Abnormalities in lipid metabolism have been associated with prevalent depression and suicide behaviour, with low concentration of plasma high-density lipoprotein (HDL) cholesterol being consistently linked to depression. 1 As most studies that have investigated this association have had a cross-sectional design, reverse causality and confounding could plausibly explain their findings. This prospective study sought to determine whether the plasma concentration of lipids, and more specifically of HDL cholesterol, was associated with increased risk of depression 5 years later, independent of cardiovascular diseases, diabetes, body mass, lifestyle factors and history of past depression.
A total of 4263 community-dwelling Australian men living in metropolitan Perth provided information about the history of past depression diagnosis or treatment and, of those, 2187 consented to the collection of a blood sample and were still alive 5.3±0.7 years later (mean ± s.d.) when 1959 completed a new assessment for depression with the Patient Health Questionnaire (PHQ-9). Participants were aged 81.6±3.6 years, and 123 of them displayed symptoms of clinically significant depression (PHQ-9Z10). The characteristics of the sample have been reported elsewhere 2 and are summarized in the Supplementary Table. A stepwise multivariate logistic regression model included age, living arrangements, physical inactivity, smoking history, history of past depression, use of statins or antidepressants, serum glucose, total plasma homocysteine, high-sensitivity C-reactive protein, triglycerides and low-density lipoprotein and HDL cholesterol. History of past depression (odds ratio (OR) ¼ 4.96, 95% confidence interval (CI) ¼ 3.22-7.65), physical inactwivity (OR ¼ 3.34, 95% CI ¼ 2.24-4.98), the halving of naturally log-transformed HDL cholesterol (OR ¼ 2.85, 95% CI ¼ 1.63-4.98) and the use of antidepressants (OR ¼ 1.81, 95% CI ¼ 1.06-3.09) were the only variables retained in the final model. The adjusted halving of naturally log-transformed HDL cholesterol was associated with depression in men both with (OR ¼ 3.13, 95% CI ¼ 1.21-8.12) and without (OR ¼ 2.73, 95% CI ¼ 1.37-5.44) the history of past depression. When exposure to HDL cholesterol was dichotomized using the reference value of 1 mmol l À 1 or less, the adjusted ORs of depression were 2.28 (95% CI ¼ 1.12-4.63) and 1.70 (95% CI ¼ 0.94-3.04) for men with and without history of past depression, respectively. Figure 1 shows the adjusted probability of depression at follow up according to HDL cholesterol measured 5 years earlier.
These results revealed a reverse dose effect of HDL cholesterol on the 5-year risk of depression, which was particularly prominent in men with history of past depression. The plasma concentration of lipids declines in very old age, 3 and this may negatively affect health. 4 Data from the Whitehall II Study have implicated low HDL cholesterol in the decline of memory over 5 years, 5 and preliminary evidence suggests that older people with low HDL cholesterol show a relative loss of cerebral grey matter volume compared with controls. 6 These findings, together with those linking low HDL cholesterol to depression, 1 suggest that lipid metabolism may have an important role in maintaining brain health. 7 Kim and colleagues 8 recruited 732 community-dwelling men and women aged 65 years or over for a study designed to assess the prevalence and 2-year incidence of dementia and depression in later life. In addition to measuring serum lipids, they extracted DNA to ascertain the serotonin gene-linked promoter region (5-HTTLPR). They found that
Letters to the Editor low HDL cholesterol was associated with depression, but this association was only significant for participants carrying one or two copies of the s-allele of the 5-HTTLPR gene, which are associated with depression in the context of environmental adversity. 9 One possible, albeit speculative, scenario would be that the brain has to handle increasing cumulative stress over time, which would decrease brain reserve and disrupt homeostatic systems. The ability of these systems to handle stress would be partly determined by susceptibility genes and partly by environmental factors, some of which would facilitate regeneration. One such factor could be HDL cholesterol.
This study presented data showing that the 5-year probability of depression in older men increases as the plasma concentration of HDL cholesterol decreases. The link between low HDL cholesterol and depression seems physiologically plausible and the results of our analyses suggest that it might be causal. Sufficiently powered randomized trials are now required to determine whether the prevalence and incidence of depression in later life can be decreased by raising the plasma concentration of HDL cholesterol through diet, exercise or other effective interventions. The influence of life stress on the progression of Parkinson's disease (PD) has received little attention. Here, we examined the effects of chronic variable stress (CVS), a widely used animal model that recapitulates core symptoms of depression, on the course of neuronal degeneration and behavioral deficits in a rat neurotoxin model of PD. Depression is highly correlated with PD and is suggested to contribute more to the lowered quality of patient life than the debilitating motor symptoms. 1 Despite the high prevalence of depression in PD patients, preclinical research on the comorbidity of these neuropsychiatric and neurodegenerative disorders remains at an early stage. Dysregulation of the stress response is purported to have a large role in the etiology/ progression of depression, and many of the brain regions involved in stress regulation are also linked to depression. 2, 3 Experimental stress or depression can lead to neurodegeneration, cellular atrophy or increased susceptibility to subsequent injury in numerous brain regions. 4 Stress was long ago hypothesized to contribute to the neuropathology of PD, possibly by increasing the vulnerability of midbrain dopamine cells to degeneration. 5 Given the strong connection between PD and depression, it is Figure 1 . The adjusted probability of depression (blue line ± 95% confidence limits in pale grey) according to the plasma concentration of HDL cholesterol measured 5 years earlier for men without (top panel) and with history of past depression (bottom panel) at the time of collection of the blood sample.
